ReWalk Robotics to Report Second Quarter 2018 Financial Results on August 14, 2018
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Aug. 10, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) today announced that the Company will release its second quarter 2018 financial results on Tuesday, August 14, 2018, before the U.S. financial markets open.
Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will host a conference call to discuss the results as follows:
| Time | 8:30 a.m. EDT |
| Toll free (U.S.) | (844) 423-9889 |
| International | (716) 247-5804 |
| Israel | 18 09 31 53 62 |
| Webcast (live and replay) | www.rewalk.com under the ‘Investors’ section. |
A replay of the conference call will be available for two weeks after the call's completion by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (International). The conference ID for the replay is 4694309. The archived webcast will be available for 30 days via the aforementioned URL.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.
Contact:
Lisa Wilson
In-Site Communications, Inc.
Investor Relations
T: (212) 452-2793
E: lwilson@insitecony.com
Latest Health & Supplement Reviews
- YuSleep Reviews (EXPOSED) Doctor Explains Deep Sleep Benefits, Hidden Risks & Real Consumers Results In 2026
- Neuro Energizer Reviews and Complaints 2026: How This Neuro-Sonic Breakthrough Is Reshaping Cognitive Therapy, Memory & Daily Focus
- Gluco6 Reviews and Complaints (March 2026) Real User Data on Natural Blood Sugar Balance and Glucose Stability